The zigzagging trajectory of the price of Daranide, now known as Keveyis, shows just how much freedom drug companies have in pricing therapies — and what a big business opportunity selling rare-disease drugs has become.
Read Full Article »This Old Drug Was Free. Now It's $109,500 a Year
Comment
Show comments
Hide Comments
